Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Corvex's Merged Financial Picture Shows Widening Losses

Corvex’s merged financial picture shows a much larger revenue base, but losses widened sharply after the combination with Corvex Legacy Holdings.

For the six months ended June 30, 2026, pro forma revenue came to $4.312 million, up from $35,000 for Corvex alone and $4.277 million for Corvex Legacy. Total costs and expenses reached $32.703 million, compared with $4.563 million for Corvex and $19.812 million for Corvex Legacy. That left a pro forma operating loss of $28.391 million, versus a $4.528 million loss for Corvex and a $15.535 million loss for Corvex Legacy.

Below the operating line, Corvex booked $2.501 million in gain on disposal of assets, helping offset expenses. Even so, the combined company posted a net loss of $26.155 million, compared with Corvex’s $2.228 million loss and Corvex Legacy’s $15.542 million loss. After preferred dividends, net loss attributable to common stockholders was $26.310 million. Pro forma net loss per share was $0.94, based on 27.905 million weighted average shares.

For full-year 2025, the combined company would have generated $7.535 million of revenue, up from $433,000 for Corvex and $7.102 million for Corvex Legacy. Total costs and expenses would have been $73.045 million, including $43.681 million of general and administrative expense and $11.366 million of technology and infrastructure expense. That produced a pro forma operating loss of $64.791 million.

The 2025 bottom line was a net loss of $67.546 million, compared with Corvex’s $18.285 million loss and Corvex Legacy’s $9.517 million loss. Pro forma net loss per share was $2.62, versus $21.79 for Corvex alone and $1.59 for the legacy business. Weighted average shares used in the calculation rose to 25.818 million from 840,720 for Corvex and 24.977 million for Corvex Legacy. As a result of these announcements, the company's shares have moved 2.93% on the market, and are now trading at a price of $14.74. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS